Article Details

Dosing of ISM001-055, Oral IPF Therapy, Begins in Phase 1 Trial - Pulmonary Fibrosis News

Retrieved on: 2022-03-07 19:36:16

Tags for this article:

Click the tags to see associated articles and topics

Dosing of ISM001-055, Oral IPF Therapy, Begins in Phase 1 Trial - Pulmonary Fibrosis News. View article details on hiswai:

Excerpt

... treatment of idiopathic pulmonary fibrosis (IPF) developed using an artificial intelligence (AI) platform, Insilico Medicine announced.

Article found on: pulmonaryfibrosisnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up